Clinical Trials Browser

Phase 1/2 × NETWORK × Panitumumab × Clear all

NCT01591421 2023-08-04

P13Kinase Inhibitor BKM120 in Combination With Panitumumab in Metastatic/Advanced RAS-Wild Type Colorectal Cancer.

Phase 1/2 Completed

Gastrointestinal

Colorectal Neoplasms